UTGIVER AV

 

Utgave for helsepersonell

blodtrykk

Illustrasjonsfoto

Hypertensjon, eller høyt blodtrykk, betyr at trykket i kroppens pulsårer er høyere enn det som defineres som normalt.

  • Sist endret: 26.12.2012
  • Sist revidert: 26.12.2012

Vil du vite mer?

Dette dokumentet er basert på det profesjonelle dokumentet "Høyt blodtrykk" i Norsk Elektronisk Legehåndbok. Referanselisten for dette dokumentet vises nedenfor.

Referanser

  1. Klemsdal TO, Tonstad S, Hjermann I. Hvordan identifisere personer med høy risiko for kardiovaskulær sykdom?. Tidsskr Nor Lægeforen 2004; 124: 799-801. Tidsskriftet
  2. Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. Am Fam Physician 2010; 82: 1471-8. AFP
  3. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. EHJ
  4. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10(Suppl 1): S1-78.
  5. Getz L, Sigurdsson JA, Hetlevik I, Kirkengen AL, Romundstad S, Holmen J. Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study. BMJ 2005; 331: 551. BMJ
  6. Wills AK, Lawlor DA, Matthews FE, et al. Life course trajectories of systolic blood pressure using longitudinal data from eight UK cohorts. PlosMed 2011; 8: e1000440. PubMed
  7. Powers B, Olsen MK, Smith VA, et al. Measuring blood pressure for decision making and quality reporting: where and how many measures. Ann Intern Med 2011; 154: 781-8. AIM
  8. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004; 27: 193-202. PubMed
  9. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; : NEJMoa0907355.
  10. Klatsky AL, Gunderson E. Alcohol and hypertension: a review. J Am Soc Hypertens 2008; 2: 307-17. PubMed
  11. Malinski MK, Sesso HD, Lopez-Jimenez F, Buring JE, Gaziano JM. Alcohol consumption and cardiovascular disease mortality in hypertensive men. Arch Intern Med 2004; 164: 623-8. PubMed
  12. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001; 38: 1112-7. PubMed
  13. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(5 pt 1):2460-2470.
  14. Jones DW, Appel LJ, Sheps SG, Roccella EJ, Lenfant C. Measuring blood pressure accurately. New and persistent challenges. JAMA 2003; 289: 1027-30. JAMA
  15. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508-15. PubMed
  16. Verberk WJ, Kroon AA, Kessels AG, de Leeuw PW. Home blood pressure measurement. A systematic review. J Am Coll Cardiol 2005; 46: 743-51. PubMed
  17. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87. PubMed
  18. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(5 pt 1):2460-2470.
  19. Mayor S. Hypertension diagnosis should be based on ambulatory blood pressure monitoring, NICE recommends. BMJ 2011; 343: d5421. doi:http://dx.doi.org/10.1136/bmj.d5421
  20. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet 2011; 378: 1219-30. PubMed
  21. Stergiou G, Mengden T, Padfield PL, et al. Self monitoring of blood pressure at home. BMJ 2004; 329: 870-1. BMJ
  22. Staessen JA, Thijs L et al. Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension. Substudy RCT Systolic Hypertension in Europe. JAMA 1999; 282:539-546. JAMA
  23. Staessen JA, Wang J, Gianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361: 1629-41. PubMed
  24. Dyrdal A, Lindbæk M. Diagnostikk av hypertensjon i allmennpraksis - er kontorblodtrykk tilstrekkelig? Tidsskr Nor Lægeforen 2003; 123: 147-51. Tidsskriftet
  25. Clark CE, Taylor RS, Shore AC, et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet 2012; 379: 905-14. PubMed
  26. Gerdts E, Omvik P, Mo R, Kjeldsen SE . Hypertensjon og hjertesykdom. Tidsskr Nor Lægeforen 2004; 124: 802-5. Tidsskriftet
  27. Diao D, Wright JM, Cundiff DK, et al. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012 Aug 15;8:CD006742. Cochrane
  28. Staessen JA. Blood pressure-measuring devices: time to open Pandora's box and regulate. Hypertension. 2000;35:1037. PubMed

Debattregler